InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Century Therapeutics, Inc.

IPSC Clue Score63
United States Fiscal year ends December CIK 0001850119 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Douglas Carr
3 Nov 2026
SVP Finance & Operations
Sell
266
$1.52
$404.05
Douglas Carr
14 Sep 2026
SVP Finance & Operations
Sell
1,658
$1.93
$3.20K
Gregory Russotti
14 Sep 2026
See Remarks
Sell
2,587
$1.93
$4.99K
Douglas Carr
8 Sep 2026
SVP Finance & Operations
Sell
254
$2.05
$520.70
Gregory Russotti
8 Sep 2026
See Remarks
Sell
534
$2.05
$1.09K
Douglas Carr
3 Aug 2026
SVP Finance & Operations
Sell
275
$1.98
$543.68
Douglas Carr
12 Jun 2026
SVP Finance & Operations
Sell
1,654
$2.23
$3.69K
Gregory Russotti
12 Jun 2026
See Remarks
Sell
2,584
$2.23
$5.77K
Douglas Carr
8 Jun 2026
SVP Finance & Operations
Sell
249
$2.11
$525.64
Gregory Russotti
8 Jun 2026
See Remarks
Sell
524
$2.11
$1.11K
Douglas Carr
4 May 2026
SVP Finance & Operations
Sell
264
$2.34
$618.02
Gregory Russotti
12 Mar 2026
See Remarks
Sell
10,076
$2.55
$25.68K
Douglas Carr
12 Mar 2026
SVP Finance & Operations
Sell
7,043
$2.55
$17.95K
Douglas Carr
9 Mar 2026
SVP Finance & Operations
Sell
247
$2.54
$626.39
Gregory Russotti
9 Mar 2026
See Remarks
Sell
479
$2.54
$1.21K
Douglas Carr
3 Feb 2026
SVP Finance & Operations
Sell
323
$1.82
$588.51
Gregory Russotti
8 Dec 2025
See Remarks
Sell
526
$0.53
$279.83
Douglas Carr
8 Dec 2025
SVP Finance & Operations
Sell
257
$0.53
$136.72
Chad Cowan
20 Nov 2025
Chief Scientific Officer
Sell
5,462
$0.50
$2.74K
Brent Pfeiffenberger
17 Nov 2025
President and CEO
Sell
32,456
$0.45
$14.74K
Douglas Carr
3 Nov 2025
SVP Finance & Operations
Sell
292
$0.59
$171.11
Gregory Russotti
8 Sep 2025
See Remarks
Sell
539
$0.50
$269.50
Brent Pfeiffenberger
8 Sep 2025
President and CEO
Sell
488
$0.50
$244.00
Douglas Carr
8 Sep 2025
SVP Finance & Operations
Sell
263
$0.50
$131.50
Douglas Carr
4 Aug 2025
SVP Finance & Operations
Sell
296
$0.53
$158.06
Gregory Russotti
9 Jun 2025
See Remarks
Sell
526
$0.62
$327.17
Brent Pfeiffenberger
9 Jun 2025
President and CEO
Sell
475
$0.62
$295.45
Adrienne Farid
9 Jun 2025
Chief Operations Officer
Sell
552
$0.62
$343.34
Douglas Carr
9 Jun 2025
SVP Finance & Operations
Sell
4,904
$0.62
$3.05K
Brent Pfeiffenberger
16 May 2025
President and CEO
Sell
29,552
$0.55
$16.14K
Douglas Carr
5 May 2025
SVP Finance & Operations
Sell
295
$0.55
$162.25
Adrienne Farid
5 May 2025
Chief Operations Officer
Sell
1,024
$0.55
$563.20
Douglas Carr
10 Mar 2025
SVP Finance & Operations
Sell
1,240
$0.62
$762.60
Adrienne Farid
10 Mar 2025
Chief Operations Officer
Sell
2,359
$0.62
$1.45K
Gregory Russotti
10 Mar 2025
See Remarks
Sell
2,360
$0.62
$1.45K
Brent Pfeiffenberger
10 Mar 2025
President and CEO
Sell
2,235
$0.62
$1.37K
Brent Pfeiffenberger
18 Feb 2025
President and CEO
Sell
34,712
$0.78
$27.18K
Douglas Carr
3 Feb 2025
SVP Finance & Operations
Sell
351
$0.78
$273.78
Adrienne Farid
3 Feb 2025
Chief Operations Officer
Sell
1,054
$0.78
$822.12
Douglas Carr
4 Nov 2024
SVP Finance & Operations
Sell
283
$1.23
$347.24
Adrienne Farid
4 Nov 2024
Chief Operations Officer
Sell
1,033
$1.23
$1.27K
Douglas Carr
5 Aug 2024
SVP Finance & Operations
Sell
289
$1.83
$528.00
Adrienne Farid
5 Aug 2024
Chief Operations Officer
Sell
1,073
$1.83
$1.96K
Adrienne Farid
3 May 2024
Chief Operations Officer
Sell
913
$3.11
$2.84K
Douglas Carr
3 May 2024
SVP Finance & Operations
Sell
257
$3.11
$798.24
Adrienne Farid
6 Feb 2024
Chief Operations Officer
Sell
1,784
$4.49
$8.00K
Douglas Carr
6 Feb 2024
SVP Finance & Operations
Sell
557
$4.49
$2.50K
Adrienne Farid
5 Feb 2024
Chief Operations Officer
Sell
2,035
$3.84
$7.82K
Douglas Carr
5 Feb 2024
SVP Finance & Operations
Sell
643
$3.84
$2.47K
Versant Venture Capital VI, L.P.
9 Aug 2022
10% owner
Sell
550,000
$13.03
$7.17M
Show all 72 transactions →

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 6
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 36,941,556
Sales filed before the plan box existed 1
History held since 21 Jun 2021